吉林华微电子股份有限公司 证券代码：600360 证券简称：*ST 华微 公告编号：2025-064 关于资金占用整改完成暨股票复牌公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因吉林华微电子股份有限公司（以下简称"公司"）已完成资金占用整改，北京国 府嘉盈会计师事务所（特殊普通合伙）已出具专项审核报告，公司股票将于 2025 年 8 月 19 日复牌,本公司的相关证券停复牌情况如下： | 证券代码 | 证券简称 | | 停复牌类型 | | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 600360 | *ST | 华微 | A 股 | 复牌 | | | 2025/8/18 | 2025/8/19 | 一、停牌情况概述 2025 年 8 月 13 日在指定信息披露媒体及上海证券交易所网站（www.sse.com.cn） 披露的《吉林华微电子股份有限公司关 ...

*ST华微8月18日晚间发布公告称，因公司已在停牌期限内完成资金占用整改，北京国府嘉盈会计师事 务所已出具专项审核报告，经公司向上海证券交易所申请，公司股票将于2025年8月19日开市起复牌。 （文章来源：每日经济新闻） ...

Core Viewpoint - *ST Huamei has successfully recovered all occupied funds amounting to 1.567 billion yuan from its former controlling shareholder, Shanghai Pengsheng, marking a significant progress in resolving its financial issues [2][10]. Group 1: Fund Recovery - The company announced on August 15 that it received a total of 1.567 billion yuan, which includes both the occupied funds and interest [2][10]. - The recovery consists of two parts: 2.4862 million yuan and 8.5731 million yuan in dividends for 2023 and 2024, respectively, totaling 1.10593 million yuan, which has been used to offset the occupied funds [9]. - The remaining amount of 15.56 billion yuan was paid by Yadong Investment to settle the balance of occupied funds and corresponding interest, in line with prior agreements [9]. Group 2: Share Transfer - The share transfer agreement between Shanghai Pengsheng and Yadong Investment has been completed, with the latter acquiring 22.32% of the total share capital of *ST Huamei [7]. - Prior to the transfer, Shanghai Pengsheng held 22.32% of the shares, which has now been reduced to 0% following the transfer [7]. Group 3: Regulatory Context - The company was previously suspended from trading due to failure to complete required rectifications by the deadline of August 12, 2025, as mandated by the Jilin Securities Regulatory Bureau [11][12]. - The rectification order required the company to recover 1.491 billion yuan of non-operational funds occupied by Shanghai Pengsheng and its affiliates within six months [11]. - With the resolution of the fund occupation issue, the risk of delisting for the company is expected to diminish [14].

证券代码：600360 证券简称：*ST华微 公告编号：2025-062 吉林华微电子股份有限公司 关于控股股东协议转让股份过户完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 登录新浪财经APP 搜索【信披】查看更多考评等级 ● 2025年6月25日，吉林华微电子股份有限公司（以下简称"公司"）控股股东上海鹏盛科技实业有限公 司（以下简称"上海鹏盛"）与吉林省亚东国有资本投资有限公司（以下简称"亚东投资"）、公司及全资 子公司吉林麦吉柯半导体有限公司共同签署《股份转让协议》，上海鹏盛拟通过协议转让的方式向亚东 投资转让其持有的214,326,656股公司无限售流通股股份（占公司总股本的22.32%）。 ● 公司于2025年8月14日收到上海鹏盛、亚东投资发来的中国证券登记结算有限责任公司出具的《证券 过户登记确认书》，上海鹏盛将被司法标记的1,698,113股股份解除司法标记后，上海鹏盛与亚东投资之 间协议转让股份完成了上海证券交易所合规性确认以及中国证券登记结算有限责任公司股份过户登记手 续。 一 ...

Core Viewpoint - *ST Huamei has successfully resolved the non-operating fund occupation issue with Shanghai Pengsheng and its affiliates, receiving a total of 15.67 billion yuan, which allows the company to avoid stock suspension and potential delisting risks [1][4]. Group 1: Company Actions and Financial Transactions - On August 15, *ST Huamei announced that it received a confirmation of share transfer from Shanghai Pengsheng, which involved the lifting of judicial markings on 1.6981 million shares [1]. - As of the announcement date, Aydong Investment has paid 1.556 billion yuan to *ST Huamei's designated account to repay the occupied funds and interest owed by Shanghai Pengsheng and its affiliates [1]. - The share transfer agreement involved Shanghai Pengsheng transferring 214 million shares (22.32% of total shares) to Aydong Investment, with the proceeds prioritized for repaying the occupied funds totaling 1.556 billion yuan [3]. Group 2: Regulatory Compliance and Risks - On February 12, *ST Huamei received a directive from the Jilin Securities Regulatory Bureau to recover 1.491 billion yuan of non-operating funds occupied by Shanghai Pengsheng and its affiliates within six months [2]. - Due to the negative internal control audit opinion for the fiscal year 2024 and the ongoing fund occupation issue, *ST Huamei's stock was subjected to risk warnings and potential delisting if compliance was not achieved by August 12, 2025 [2]. - Following the successful recovery of all occupied funds and interest, the company is in the process of obtaining a special verification opinion from its accounting firm to apply for stock resumption [4].

*ST华微（SH 600360，收盘价：9元）8月15日晚间发布公告称，2025年6月25日，公司控股股东上海鹏 盛与亚东投资、公司及全资子公司吉林麦吉柯半导体有限公司共同签署《股份转让协议》，上海鹏盛拟 通过协议转让的方式向亚东投资转让其持有的约2.14亿股公司无限售流通股股份（占公司总股本的 22.32%），转让价款优先用于偿还上海鹏盛及其关联方占用公司资金余额及利息共计约15.56亿元。公 司于2025年8月14日收到上海鹏盛、亚东投资发来的中国证券登记结算有限责任公司出具的《证券过户 登记确认书》，上海鹏盛将被司法标记的约170万股股份解除司法标记后，上海鹏盛与亚东投资之间协 议转让股份完成了上海证券交易所合规性确认以及中国证券登记结算有限责任公司股份过户登记手续。 2024年1至12月份，*ST华微的营业收入构成为：工业占比96.92%，商业占比1.74%，服务业占比 0.82%，其他业务占比0.52%。 （文章来源：每日经济新闻） ...

证券代码：600360 证券简称：*ST 华微 公告编号：2025-062 吉林华微电子股份有限公司 关于控股股东协议转让股份过户完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司于 2025 年 8 月 14 日收到上海鹏盛、亚东投资发来的中国证券登记结 算有限责任公司出具的《证券过户登记确认书》，上海鹏盛将被司法标记的 1,698,113 股股份解除司法标记后，上海鹏盛与亚东投资之间协议转让股份完成了 上海证券交易所合规性确认以及中国证券登记结算有限责任公司股份过户登记手续。 一、协议转让前期基本情况 2025 年 6 月 25 日，公司控股股东上海鹏盛与亚东投资、公司及全资子公司吉 林麦吉柯半导体有限公司共同签署《股份转让协议》，上海鹏盛拟通过协议转让的 方式向亚东投资转让其持有的 214,326,656 股公司无限售流通股股份（占公司总股 本的 22.32%），转让价款优先用于偿还上海鹏盛及其关联方占用公司资金余额（扣 减上海鹏盛 2023 年度、2024 年度分红款）及利息共计 155, ...

证券代码：600360 证券简称：*ST 华微 公告编号：2025-063 吉林华微电子股份有限公司 关于收到原控股股东归还全部占用资金及利息的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司于 2025 年 2 月 12 日收到中国证监会吉林监管局下发的《关于对吉林华微 电子股份有限公司、上海鹏盛科技实业有限公司采取责令改正措施的决定》（吉证 监决〔2025〕4 号），要求公司在 6 个月内清收 149,067.82 万元被上海鹏盛及其关 联方非经营性占用的资金。 公司前期已收到上海鹏盛的《关于资金占用整改方案的承诺函》，上海鹏盛提 出 了 资 金 占 用 整 改 方 案 ， 向 上 市 公 司 归 还 全 部 占 用 资 金 并 支 付 利 息 共 计 156,695.89 万元，其中：上海鹏盛将以分红款抵偿 1,105.93 万元，并以向亚东投 资转让所持公司全部股份所得资金清偿 155,589.96 万元。上述资金占用整改方案 已经公司第九届董事会第九次会议、第九届监事会第五次会议、2025 ...

Audit Opinion - The audit report states that the financial statements of Chengdu Zhongke Huami Microelectronics Co., Ltd. fairly reflect the company's financial position as of December 31, 2024, and March 31, 2025, in accordance with accounting standards [1][2]. Basis for Audit Opinion - The audit was conducted following the Chinese Certified Public Accountant Auditing Standards, ensuring independence and adherence to professional ethics [2][3]. Management and Governance Responsibilities - The management is responsible for preparing the financial statements in accordance with accounting standards and maintaining internal controls to prevent material misstatements due to fraud or error [2][3]. Auditor's Responsibilities - The auditor's goal is to obtain reasonable assurance that the financial statements are free from material misstatement, whether due to fraud or error, and to issue an audit report that includes the audit opinion [3][4]. Financial Position - As of March 31, 2025, the total assets of the company amounted to CNY 291,835,115.98, compared to CNY 273,351,433.20 as of December 31, 2024 [6][7]. - The total liabilities and equity also matched the total assets at CNY 291,835,115.98 as of March 31, 2025 [7]. Income Statement - For the first quarter of 2025, the total operating income was CNY 48,022,888.82, while for the entire year of 2024, it was CNY 100,528,105.71 [6][8]. - The net profit for the first quarter of 2025 was CNY 20,126,922.77, compared to CNY 32,905,827.02 for the full year of 2024 [8]. Cash Flow Statement - The net cash flow from operating activities for the first quarter of 2025 was negative at CNY -13,175,072.81, while for the full year of 2024, it was CNY -14,740,200.20 [8]. - The net cash flow from investing activities was also negative at CNY -16,259,345.86 for the first quarter of 2025 [8]. Changes in Equity - The total equity attributable to the parent company as of March 31, 2025, was CNY 110,730,206.56, an increase from CNY 105,955,783.79 as of December 31, 2024 [7].

康达新材（SZ 002669，收盘价：13.8元）8月14日晚间发布公告称，公司拟以现金方式使用自有及自筹 资金人民币约2.75亿元收购成都中科华微电子有限公司（简称"中科华微"）51%的股权。交易完成后， 中科华微将成为公司的控股子公司，并纳入公司合并报表范围。 （文章来源：每日经济新闻） 2024年1至12月份，康达新材的营业收入构成为：胶粘剂行业占比72.62%，电子产品业务占比8.48%， 合成树脂占比6.1%，其他业务占比4.28%，医药中间体占比3.31%。 ...